KDM5A methylation modulates its genomic demethylase and transcriptional actions

Area of Science:

• Biochemistry
• Molecular Biology
• Epigenetics

Background:

• The KDM5 family of Jumonji histone demethylases is linked to human diseases like cancer and neurological disorders.
• Mechanisms regulating KDM5 enzyme activity and levels remain largely unknown.

Purpose of the Study:

• To investigate the regulatory mechanisms of KDM5A, a key member of the KDM5 family.
• To elucidate the functional consequences of post-translational modifications on KDM5A activity and cellular function.

Main Methods:

• Investigated the interaction between KDM5A and SMYD2.
• Analyzed the effects of KDM5A methylation at K1063 on its demethylase activity, genomic binding, and protein interactome.
• Assessed the impact of these modifications on gene expression and cancer cell proliferation.

Main Results:

• KDM5A is methylated by SMYD2, which reduces its histone demethylase activity and alters its protein interactions.
• A K1063A mutant KDM5A displayed altered genomic targeting, enhanced H3K4me3 demethylation, distinct transcriptional effects, and unique protein interactions.
• These changes led to the modulation of cell proliferation pathways and a reduction in cancer cell growth.

Conclusions:

• Lysine methylation is a critical regulatory mechanism for KDM5A.
• Post-translational modifications of KDM5 enzymes significantly impact histone demethylation, gene expression, protein interactions, and growth signaling.
• This study highlights lysine methylation as a key event in KDM5A function with implications for disease and therapeutic development.